Medipure is developing an extensive network of strategic partnerships with extensive experience in developing cannabinoids, medicines containing controlled substances, as well as plant-based prescription pharmaceutical products. Medipure will attempt to bring novel prescription medicines to market, providing patients with serious conditions valuable solutions that make a real difference to quality of life.  MEDIPURE HOLDINGS INC. 16/08/2016 2016-0817 - DELIST - MEDIPURE HOLDINGS INC. (MDH) AUGUST 16, 2016 THE COMMON SHARES OF MEDIPURE HOLDINGS INC. WILL BE DELISTED AT THE MARKET CLOSE TODAY, AUGUST  16, 2016.  MEDIPURE HOLDINGS IS CURRENTLY SUSPENDED. DATE: MARKET CLOSE, AUGUST 16, 2016 SYMBOL: MDH
WKN: A12EZX ISIN: Kürzel: MDH   in  handelbar: NEIN 

Gründungsjahr: k.A. Haupthandelsplatz  Vollzogene Namenswechsel- Land   Angestellte: k.A.

Matica Enterprises Inc.                                                                                                                                                                            Mettrum Health